Medicine

A new study suggests plitidepsin, an eEF1A inhibitor could be used as a COVID-19 antiviral. A large multinational team...

As we usher in the new normal phase, innovations to healthcare and every other basic aspect of society begin...

The novel coronavirus (nCoV-19) or the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new public health crisis...

According to the Global Cancer Observatory (GLOBOCAN), in 2018, cervical cancer was the fourth most common type of cancer...

Smartwatches have been gaining increased popularity over recent years, with annual sales of several hundred million units worldwide. Among...

Pain is one of the most fundamental mechanisms of self-preservation. Acute pain, unpleasant as it may be, is a...

In January of 2015, following years of rapid and exciting development in the field of genomics, the US government...

The FDA has approved a new drug, Exondys 51, manufactured by Sarepta Therapeutics that targets exon 51 skipping. This...

Liraglutide (Victoza®) is an injectable glucagon-like peptide-1 (GLP-1) receptor antagonist indicated in addition to diet and exercise to improve...